Hits, Fhits and Nits: beyond enzymatic function.

We have briefly summarized what is known about these proteins, but in closing wish to feature the outstanding questions. Hint1 was discovered mistakenly as an inhibitor of Protein Kinase C and designated Pkci, a designation that still confuses the literature. The other Hint family members were discovered by homology to Hint1. Aprataxin was discovered as a result of the hunt for a gene responsible for AOA1. Fhit was discovered through cloning of a familial chromosome translocation breakpoint on chromosome 3 that interrupts the large FHIT gene within an intron, in the FRA3B chromosome region (Ohta et al., 1996), now known to be the region of the human genome most susceptible to DNA damage due to replication stress (Durkin et al., 2008). The NitFhit fusion genewas discovered during searches for Fhit homologs in flies and worms because the fly/worm Nit polypeptide is fused to the 5'-end of the Fhit gene; the mammalian Nit gene family was discovered because of the NitFhit fusion gene, in searches for homologs to the Nit polypeptide of the NitFhit gene. Each of the Hit family member proteins is reported to have enzymatic activities toward putative substrates involving nucleosides or dinucleosides. Most surprisingly, each of the Hit family proteins discussed has been implicated in important DNA damage response pathways and/or tumor suppression pathways. And for each of them it has been difficult to assign definite substrates, to know if the substrates and catalytic products have biological functions, to know if that function is related to the DNA damage response and suppressor functions, and to precisely define the pathways through which tumor suppression occurs. When the fly Nit sequence was found at the 5'-end of the fly Fhit gene, this gene was hailed as a Rosetta stone gene/protein that would help in discovery of the function of Fhit, because the Nit protein should be in the same signal pathway (Pace et al., 2000). However, the mammalian Nit family proteins have turned out to be at least as mysterious as the Fhit proteins, with the Nit1 substrate still unknown and the surprising finding that Nit proteins also appear to behave as tumor suppressor proteins. Whether the predicted enzymatic functions of these proteins are relevant to the observed biological functions, remain among the outstanding unanswered puzzles and raise the question: have these mammalian proteins evolved beyond the putative original enzymatic purpose, such that the catalytic function is now vestigial and subservient to signal pathways that use the protein-substrate complexes in pathways that signal apoptosis or DNA damage response? Or can these proteins be fulfilling catalytic functions independently but in parallel with signal pathway functions, as perhaps observed for Aprataxin? Or is the catalytic function indeed part of the observed biological functions, such as apoptosis and tumor suppression? Perhaps the recent, post-genomic focus on metabolomics and genome-wide investigations of signal pathway networks will lead to answers to some of these outstanding questions.

[1]  C. Croce,et al.  The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.

[2]  A. McLennan,et al.  The Fhit tumor suppressor protein regulates the intracellular concentration of diadenosine triphosphate but not diadenosine tetraphosphate. , 2000, Cancer research.

[3]  K. Huebner,et al.  The histidine triad superfamily of nucleotide‐binding proteins , 1999, Journal of cellular physiology.

[4]  C. Croce,et al.  Fragile gene product, Fhit, in oxidative and replicative stress responses , 2009, Cancer science.

[5]  J. Sun,et al.  Nit1 and Fhit tumor suppressor activities are additive , 2009, Journal of cellular biochemistry.

[6]  L. D. Barnes,et al.  Adenosine Monophosphoramidase Activity of Hint and Hnt1 Supports Function of Kin28, Ccl1, and Tfb3* 210 , 2002, The Journal of Biological Chemistry.

[7]  K. Caldecott,et al.  Short-patch single-strand break repair in ataxia oculomotor apraxia-1. , 2009, Biochemical Society transactions.

[8]  Haiyang Li,et al.  Hint1 is a haplo-insufficient tumor suppressor in mice , 2006, Oncogene.

[9]  K. Huebner,et al.  Involvement of the Fhit gene in the ionizing radiation‐activated ATR/CHK1 pathway , 2005, Journal of cellular physiology.

[10]  D. Iliopoulos,et al.  Biological Functions of Mammalian Nit1, the Counterpart of the Invertebrate NitFhit Rosetta Stone Protein, a Possible Tumor Suppressor* , 2006, Journal of Biological Chemistry.

[11]  L. D. Barnes,et al.  The role of the FHIT/FRA3B locus in cancer. , 1998, Annual review of genetics.

[12]  K. Caldecott,et al.  Defective DNA Ligation during Short-Patch Single-Strand Break Repair in Ataxia Oculomotor Apraxia 1 , 2008, Molecular and Cellular Biology.

[13]  Y. Pekarsky,et al.  Crystal structure of the worm NitFhit Rosetta Stone protein reveals a Nit tetramer binding two Fhit dimers , 2000, Current Biology.

[14]  L. D. Barnes,et al.  The Tumor Suppressor Protein Fhit , 1999, The Journal of Biological Chemistry.

[15]  C. Croce,et al.  Fhit modulates the DNA damage checkpoint response. , 2006, Cancer research.

[16]  L. D. Barnes,et al.  Correlation of Fragile Histidine Triad (Fhit) Protein Structural Features with Effector Interactions and Biological Functions* , 2009, Journal of Biological Chemistry.

[17]  T. Gibson,et al.  The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin , 2001, Nature Genetics.

[18]  Y. Pekarsky,et al.  Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. D. Barnes,et al.  Cloning of the Schizosaccharomyces pombe gene encoding diadenosine 5',5"'-P1,P4-tetraphosphate (Ap4A) asymmetrical hydrolase: sequence similarity with the histidine triad (HIT) protein family. , 1995, The Biochemical journal.

[20]  J. Harris,et al.  Aprataxin Forms a Discrete Branch in the HIT (Histidine Triad) Superfamily of Proteins with Both DNA/RNA Binding and Nucleotide Hydrolase Activities* , 2006, Journal of Biological Chemistry.

[21]  H. Ishii,et al.  Molecular parameters of genome instability: Roles of fragile genes at common fragile sites , 2008, Journal of cellular biochemistry.

[22]  C. Lima,et al.  Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Huebner,et al.  Identification of the putative tumor suppressor Nit2 as omega-amidase, an enzyme metabolically linked to glutamine and asparagine transamination. , 2009, Biochimie.

[24]  C. Croce,et al.  Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies. , 2001, JAMA.

[25]  O. Huber,et al.  The tumor suppressor Fhit acts as a repressor of β-catenin transcriptional activity , 2007, Proceedings of the National Academy of Sciences.

[26]  S. Sugano,et al.  Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene , 2001, Nature Genetics.

[27]  H. Ishii,et al.  A Fhit-ing Role in the DNA Damage Checkpoint Response , 2007, Cell cycle.

[28]  J. Minna,et al.  Synergistic Tumor Suppression by Coexpression of FHIT and p53 Coincides with FHIT-Mediated MDM2 Inactivation and p53 Stabilization in Human Non-Small Cell Lung Cancer Cells , 2004, Cancer Research.

[29]  C. Croce,et al.  The tumor spectrum in FHIT-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  I. Weinstein,et al.  Histidine Triad Nucleotide-binding Protein 1 Up-regulates Cellular Levels of p27KIP1 by Targeting ScfSKP2 Ubiquitin Ligase and Src* , 2009, Journal of Biological Chemistry.

[31]  Charles Brenner,et al.  Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. , 2002, Biochemistry.

[32]  Haiyang Li,et al.  The HINT1 tumor suppressor regulates both γ-H2AX and ATM in response to DNA damage , 2008, The Journal of cell biology.

[33]  O. Huber,et al.  The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF–β-catenin-mediated transcription , 2005, Journal of Cell Science.

[34]  S. Warren,et al.  Replication stress induces tumor-like microdeletions in FHIT/FRA3B , 2008, Proceedings of the National Academy of Sciences.

[35]  C. Brenner,et al.  The nitrilase superfamily: classification, structure and function , 2001, Genome Biology.

[36]  M. L. Le Beau,et al.  Common fragile sites are characterized by histone hypoacetylation , 2009, Human molecular genetics.

[37]  T. Chou,et al.  Phosphoramidate pronucleotides: a comparison of the phosphoramidase substrate specificity of human and Escherichia coli histidine triad nucleotide binding proteins. , 2007, Molecular pharmaceutics.

[38]  Arthur J. L. Cooper,et al.  Assay and purification of omega-amidase/Nit2, a ubiquitously expressed putative tumor suppressor, that catalyzes the deamidation of the alpha-keto acid analogues of glutamine and asparagine. , 2009, Analytical biochemistry.

[39]  L. D. Barnes,et al.  Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. Croce,et al.  Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Paterson,et al.  Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. , 2000 .

[42]  L. D. Barnes,et al.  Replacement of Fhit in cancer cells suppresses tumorigenicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Stevens,et al.  Functional proteomic and structural insights into molecular recognition in the nitrilase family enzymes. , 2008, Biochemistry.

[44]  C. Croce,et al.  Fhit Interaction with Ferredoxin Reductase Triggers Generation of Reactive Oxygen Species and Apoptosis of Cancer Cells* , 2008, Journal of Biological Chemistry.

[45]  M. Veiga-da-Cunha,et al.  Molecular identification of omega-amidase, the enzyme that is functionally coupled with glutamine transaminases, as the putative tumor suppressor Nit2. , 2009, Biochimie.

[46]  K. Huebner,et al.  Pathology and biology associated with the fragile FHIT gene and gene product , 2010, Journal of cellular biochemistry.

[47]  L. D. Barnes,et al.  Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase. , 1996, Biochemistry.

[48]  S. Thorgeirsson,et al.  Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. , 2006, Gastroenterology.